CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be tied to COVID-19 vaccine equity, investors say
CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be [...]
CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be [...]
Merck’s Keytruda scores key NICE sign-off for first-line NSCLC indication [...]
FDA must hit the gas on FOIA request tied to [...]
Regeneron hands over Evkeeza rights to Ultragenyx outside US, with [...]
Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm’s [...]
Blueprint’s Ayvakit launch ramps up as it taps LabCorp, new [...]
Viatris shareholders rail against execs’ hefty pay packages fkansteiner Thu, [...]
Pfizer, Roche, AstraZeneca and J&J face newly revived lawsuit claiming [...]
AstraZeneca, Amgen tap Brand Institute in new naming twist for [...]
Pfizer carries pandemic momentum into 2022, scoring another huge Paxlovid [...]